Clinical Trial Update: Dose Escalation Study of RAD001 in Combination w/Chemotherapy & Radiation in Patients With NSCLC [Phase 1]

View source ↗

Summary

A Phase 1 dose-escalation study of RAD001 (everolimus) in combination with chemotherapy and radiation for non-small cell lung cancer was terminated. The update …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• RAD001 (Everolimus) (everolimus)

Snippet

Sponsor: University of Chicago | Conditions: Non-Small Cell Lung Cancer | Phase 1 | Status: TERMINATED